Leaflet BINOSTO 70mg effervescent tablets

Indicated for: osteoporosis

Route of administration: oral

Substance: alendronic acid (bisphosphonate)

ATC: M05BA04 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates)

Precautions:
Take on an empty stomach
Take on an empty stomach

Take this medicine on an empty stomach.

Avoid milk, calcium, iron, or antacids
Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

Alendronic acid is a medication used for the prevention and treatment of osteoporosis, a condition characterized by decreased bone density and an increased risk of fractures. It is particularly indicated for postmenopausal women, men at risk of bone loss, and patients undergoing long-term corticosteroid therapy.

Alendronic acid belongs to the bisphosphonate class and works by inhibiting bone resorption, reducing the activity of osteoclasts (cells that break down bone). This helps maintain bone density and reduces the risk of fractures, especially in the hip and spine.

Side effects may include esophageal irritation, abdominal pain, nausea, or heartburn. To minimize these risks, the medication should be taken in the morning on an empty stomach with a full glass of water, and the patient should remain upright for at least 30 minutes after administration.

General data about BINOSTO 70mg

  • Substance: alendronic acid
  • Date of latest medicines list: 01-06-2026
  • Product code: W63265001
  • Concentration: 70mg
  • Pharmaceutical form: effervescent tablets
  • Quantity: 4
  • Product type: Generic medicine
  • Price: 68.94 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: TEMMLER PHARMA GMBH & CO. KG - GERMANIA
  • Holder: GALENICA S.A. - GRECIA
  • Number: 11489/2019/01
  • Shelf life: 4 years

Pharmaceutical forms available for alendronic acid

Concentrations available for alendronic acid

  • 10mg
  • 5mg
  • 70mg
  • 70mg/2800UI
  • 70mg/5600UI

Compensation lists for BINOSTO 70mg Galenica

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

68.94 RON

12.25 RON

56.69 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

68.94 RON

17.76 RON

51.18 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

68.94 RON

17.76 RON

51.18 RON